Albemarle GC awarded 1,796 restricted stock units

Krupa Ander C. reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Krupa Ander C. reported acquisition or exercise transactions in this Form 4 filing.

Albemarle Corp reported that its General Counsel & Secretary, Ander C. Krupa, was granted 1,796 restricted stock units on March 2, 2026. According to the award terms, these restricted stock units vest 100% on March 2, 2029, increasing the officer’s directly held common stock-related interest to 13,184 shares after the award.

Insider Trade Summary

Grant/Award: 1,796 shares

Grant/Award 1 txn

Insider Krupa Ander C.

Role General Counsel & Sec

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,796	$0.00	$0.00

Holdings After Transaction: Common Stock — 13,184 shares (Direct)

Footnotes (1)

F1. Restricted Stock Units vest 100% on 03/02/2029, subject to the terms of the award agreement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity award did Albemarle (ALB) report for Ander C. Krupa?

Albemarle reported that General Counsel & Secretary Ander C. Krupa received an award of 1,796 restricted stock units. These units are tied to Albemarle common stock and were recorded at a price of $0.00 per share as part of an equity compensation grant.

When do Ander C. Krupa’s Albemarle (ALB) restricted stock units vest?

The restricted stock units granted to Ander C. Krupa vest 100% on March 2, 2029. Vesting is subject to the terms and conditions in the applicable award agreement governing this grant of Albemarle equity-based compensation.

How many Albemarle (ALB) shares does Ander C. Krupa hold after this Form 4 transaction?

After the reported equity grant, Ander C. Krupa is shown as holding 13,184 shares of Albemarle common stock-related interests directly. This total includes the impact of the 1,796 restricted stock units reported in the latest Form 4 filing.

What was the transaction type reported in Albemarle (ALB) insider filing for Ander C. Krupa?

The filing classifies the transaction as a grant, award, or other acquisition of securities under code “A.” This represents an acquisition of 1,796 restricted stock units rather than an open-market purchase or sale of Albemarle common stock.

Is Ander C. Krupa considered a company insider at Albemarle (ALB)?

Yes. The filing identifies Ander C. Krupa as an officer of Albemarle, serving as General Counsel & Secretary. As a corporate officer, Krupa is treated as an insider for reporting purposes on Form 4 transactions in Albemarle securities.

Did Ander C. Krupa buy or sell Albemarle (ALB) shares on the market in this Form 4?

No market buy or sell is reported. The Form 4 describes a grant or award transaction coded as an acquisition of 1,796 restricted stock units, with a stated transaction price of $0.00 per share rather than an open-market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/04/2026 - 06:29 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krupa Ander C.

(Last)

(First)

(Middle)

4250 CONGRESS STREET

SUITE 900

(Street)

CHARLOTTE

28209

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	General Counsel & Sec

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/02/2026		A		1,796⁽¹⁾	A	$0	13,184	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted Stock Units vest 100% on 03/02/2029, subject to the terms of the award agreement.

Remarks:

	/s/ Corey E. Tanner, Attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR